NF2 and schwannoma: This novel mechanism could explain why DCAF1 knockdown leads to reduced pERK1/2 levels in Merlin-deficient schwannoma, and why combined shRNA knockdown of DCAF1 and KSR1 reduced the proliferation of schwannoma cells [18].